Back to Agenda
Session 2, Track B: Re-Defining Patient-Centric Clinical Research
Session Chair(s)
Sabrina Ramkellawan
President and Board Director
Clinical Research Association of Canada, Canada
Stephanie Anderson, MS
Associate Director, Regulatory Affairs
Intrinsik Corp., Canada
This session explores the evolving landscape of clinical trials through the patient perspective and modern trial approaches. Attendees will gain insights into patient-centric, fit-for-purpose trial designs and the lived experiences shaping Diversity, Equity, and Inclusion in Clinical Trials (DEICT). Real-world case studies and personal narratives will highlight how modern approaches and the use of AI are transforming both study conduct and participant engagement.
- “Fit-for-Purpose” Clinical Trials with Decentralized Elements
Aneta Woroniecka-Osio, Independent - An Inclusive Perspective About Clinical Research – From Patient to Clinical Research Professional
Adriana Rodriguez Cruz, Global Health Equity Advocate - An Agentic Approach to Patient-Centric Clinical Research
Mark Baxter, RxPx Health
Learning Objective : - Employ strategies to develop patient-centric approaches with a DEICT perspective
- Discuss the lived experiences of patients while exploring the patient and clinical research professional perspectives
- Contrast modern vs classical approaches in patient engagement and study conduct
- Identify modernization of clinical trials including the evolution of decentralized trials, use of AI digital applications, and fit for purpose study design
Speaker(s)
Evolution in Decentralized Clinical Trials - Patient-centric, Fit for Purpose Approach to Modernize Study Conduct
Aneta Woroniecka-Osio, MD
Bayer, Canada
Manager, SCI
An Agentic Approach to Patient-Centric Clinical Research
Mark Baxter
RxPx Health, Canada
Chief Product Officer
An Inclusive Perspective About Clinical Research – From Patient to Clinical Research Professional
Adriana Rodriguez Cruz, PhD
Global Health Equity Advocate, Canada
Have an account?